NCT01040156

Antimycotic Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation

Safety, Feasibility and Efficacy of Caspofungin Versus Liposomal Amphotericin B as Antifungal Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients - a Retrospective Phase I/II Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: —
• Sponsor: University Children's Hospital Tuebingen · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

Pediatric patients are at high risk to acquire mycotic infections following allogeneic bone marrow transplantation. In the present retrospective analysis we assess the safety and efficacy of different regimens in antimycotic prophylaxis.

Conditions

• Systemic Aspergillosis
• Systemic Candidiasis

Timeline

• Start date: 2008-08-01
• Primary completion: 2009-12-01
• Completion: 2009-12-01
• First posted: 2009-12-29
• Last updated: 2009-12-29

Locations

1 site across 1 country: Germany